Pharma-Bio Serv (PBSV) Exchange Rate Effect (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Exchange Rate Effect of -$1366.0 for Q2 2026, down 102.65% year-over-year from $51541.0 in Q2 2025, and down 114.41% on a QoQ basis from $9482.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Exchange Rate Effect history runs 17 years deep, the most recent figure standing at -$1366.0 for Q2 2026.
- Exchange Rate Effect for Q2 2026 came in at -$1366.0, down 102.65% year-over-year; the trailing twelve-month figure through Apr 2026 was $20154.0 (down 10.74% YoY), and the FY2025 annual result was $44494.0, up 352.38% from the prior year.
- Exchange Rate Effect came in at -$1366.0 for Q2 2026 at Pharma-Bio Serv, down from $9482.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $90619.0 in Q1 2023 to a low of -$58225.0 in Q4 2023.
- A 5-year average of $2979.4 and a median of -$1933.0 in 2023 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect plunged 568.95% in 2022 and soared 1509.75% in 2023, its largest moves.
- Over 5 years, Exchange Rate Effect stood at -$21675.0 in 2022, then sank by 168.63% to -$58225.0 in 2023, then soared by 95.22% to -$2783.0 in 2024, then surged by 375.28% to $7661.0 in 2025, then plunged by 117.83% to -$1366.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$1366.0 (Q2 2026), $9482.0 (Q1 2026), and $7661.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | -532,000.00 |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -73,000.00 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | - |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | -1.09 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | -1,366.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1,366.00 |
| Apr 30, 2026 | -1,366.00 |
| Jan 31, 2026 | 9,482.00 |
| Jan 31, 2026 | 9,482.00 |
| Oct 31, 2025 | 7,661.00 |
| Oct 31, 2025 | 7,661.00 |
| Jul 31, 2025 | 4,377.00 |
| Jul 31, 2025 | 4,377.00 |
| Apr 30, 2025 | 51,541.00 |
| Apr 30, 2025 | 51,541.00 |
| Jan 31, 2025 | -19,085.00 |
| Jan 31, 2025 | -19,085.00 |
| Oct 31, 2024 | -2,783.00 |
| Oct 31, 2024 | -2,783.00 |
| Jul 31, 2024 | -7,094.00 |
| Jul 31, 2024 | -7,094.00 |
| Apr 30, 2024 | -19,896.00 |
| Apr 30, 2024 | -19,896.00 |
| Jan 31, 2024 | 12,143.00 |
| Jan 31, 2024 | 12,143.00 |